Submission Details
| 510(k) Number | K210201 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 25, 2021 |
| Decision Date | August 17, 2021 |
| Days to Decision | 204 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K210201 is an FDA 510(k) clearance for the Deep Transcranial Magnetic Stimulation (DTMS) System, a Transcranial Magnetic Stimulator (Class II — Special Controls, product code OBP), submitted by Brainsway , Ltd. (Jerusalem, IL). The FDA issued a Cleared decision on August 17, 2021, 204 days after receiving the submission on January 25, 2021. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5805.
| 510(k) Number | K210201 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 25, 2021 |
| Decision Date | August 17, 2021 |
| Days to Decision | 204 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | OBP — Transcranial Magnetic Stimulator |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5805 |
| Definition | A Transcranial Magnetic Stimulator Is A Device That Delivers Brief Duration, Rapidly Alternating, Or Pulsed, Magnetic Fields To Induce Electrical Currents That Are Directed At Spatially Discrete Regions Of The Cerebral Cortex For The Treatment Of Major Depressive Disorder. |